20-30% of prescriptions will never be filled (see: https://www.ncbi.nlm.nih.gov/pubmed/22964778 ). The stats may be higher for SAS products such as medicinal cannabis.
The good news is that even if we’re assuming a 50% fill rate, that’s still pretty decent income for MXC. We’re on the right track people!
20-30% of prescriptions will never be filled (see:...
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.90M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 2500 | 1 |
View Market Depth
| Last trade - 16.12pm 18/10/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable